Clinical trials
Communication Disorders trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
45 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 13 |
| Not yet recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Albert Einstein Healthcare Network | 3 |
| VA Office of Research and Development | 3 |
| Altec Inc. | 2 |
| NYU Langone Health | 2 |
| Syracuse University | 2 |
| University of South Carolina | 2 |
| Boston University Charles River Campus | 1 |
| Casa Colina Hospital and Centers for Healthcare | 1 |
| City University of New York | 1 |
| Connecticut Children's Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communication Disorders | 45 |
| Aphasia | 21 |
| Stroke | 13 |
| Anomia | 6 |
| Language Disorders | 5 |
| Aphasia, Primary Progressive | 3 |
| Apraxias | 3 |
| Autism Spectrum Disorder | 3 |
| Autistic Disorder | 3 |
| Alzheimer Disease | 2 |
Trials
Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.